1-20 of 59 results for subject:"Medical treatments"
Librarians' tools
- Search time
- 0.233 seconds
- Solr query time
- 0.009 seconds
- Search query
- subject:"Medical treatments"
- We searched for
- subject_t:"Medical treatments" OR subject_ses:91973
Type
House
Session
Year
Department
Member
Primary member
More
Answering member
Legislative stage
Legislation
Subject
More
Publisher
(3) how many patients were receiving photodynamic therapy at the latest date for which figures are available;
(3) how many patients were receiving photodynamic therapy at the latest date for which figures are available;
To ask the Secretary of State for Health if he will commission research on the efficacy of photodynamic therapy; and if he will make a statement.
To ask the Secretary of State for Health if he will commission research on the efficacy of photodynamic therapy; and if he will make a statement.
(4) how many patients received photodynamic therapy in each of the last three years, broken down by hospital at which treatment was dispensed.
(4) how many patients received photodynamic therapy in each of the last three years, broken down by hospital at which treatment was dispensed.
(2) what recent representations he has received on the effectiveness of photodynamic therapy in the treatment of cancer;
(2) what recent representations he has received on the effectiveness of photodynamic therapy in the treatment of cancer;
To ask the Secretary of State for Health (1) how much funding his Department has allocated to the development of photodynamic therapy in the treatment of cancer in the next three financial years;
To ask the Secretary of State for Health (1) how much funding his Department has allocated to the development of photodynamic therapy in the treatment of cancer in the next three financial years;
To ask the Secretary of State for Health what assessment she has made of the ability of hospitals in England to treat meningitis; and what steps her Department is taking to improve the treatment of meningitis in hospitals.
To ask the Secretary of State for Health what assessment she has made of the ability of hospitals in England to treat meningitis; and what steps her Department is taking to improve the treatment of meningitis in hospitals.
To ask the Secretary of State for Health what hospital treatment protocols there are for meningitis; what such protocols have been issued in the last five years; who is responsible for issuing guidance to hospitals about the best and latest protocols for the treatment of meningitis; and if she will...
To ask the Secretary of State for Health what hospital treatment protocols there are for meningitis; what such protocols have been issued in the last five years; who is responsible for issuing guidance to hospitals about the best and latest protocols for the treatment of meningitis; and if she will...
To ask the Secretary of State for Health, pursuant to his written Answer of 13th February 2002, 380 c486W, whether the figures for finished consultant episodes with a primary diagnosis of eating disorder for 2000-01 have been adjusted for shortfalls in data; and if he will make a statement. -...
To ask the Secretary of State for Health, pursuant to his written Answer of 13th February 2002, 380 c486W, whether the figures for finished consultant episodes with a primary diagnosis of eating disorder for 2000-01 have been adjusted for shortfalls in data; and if he will make a statement. -...
To ask the Secretary of State for Health, whether he has a target for reducing the average period of untreated psychosis prior to a person receiving treatment. - (Holding answer 8 July 2002).
To ask the Secretary of State for Health, whether he has a target for reducing the average period of untreated psychosis prior to a person receiving treatment. - (Holding answer 8 July 2002).
To ask the Secretary of State for Health, what assessment he has made of the safety of UK plasma products; and if he will make a statement. - (Holding answer 11 July 2002).
To ask the Secretary of State for Health, what assessment he has made of the safety of UK plasma products; and if he will make a statement. - (Holding answer 11 July 2002).
To ask the Secretary of State for Health, what assessment he has made of the Kosmed system of treatment produced by Eumedic Limited; what plans he has to assess the Kosmed system of treatment produced by Eumedic Limited. - None. (Holding answer 4 July 2002).
To ask the Secretary of State for Health, what assessment he has made of the Kosmed system of treatment produced by Eumedic Limited; what plans he has to assess the Kosmed system of treatment produced by Eumedic Limited. - None. (Holding answer 4 July 2002).
To ask the Secretary of State for Health, what plans are in place and what the timetable is to introduce the beta interferon risk-sharing scheme to Hertfordshire.
To ask the Secretary of State for Health, what plans are in place and what the timetable is to introduce the beta interferon risk-sharing scheme to Hertfordshire.
To ask the Secretary of State for Health, how widespread the use of cognitive behaviour therapy is; and in which parts of England it is not available.
To ask the Secretary of State for Health, how widespread the use of cognitive behaviour therapy is; and in which parts of England it is not available.
To ask the Secretary of State for Health, what the timetable is for the guidelines on the management of eating disorders to be produced by NICE.
To ask the Secretary of State for Health, what the timetable is for the guidelines on the management of eating disorders to be produced by NICE.
To ask the Secretary of State for Health, if he intends to restrict the use of typical anti-psychotic drugs to a named patient basis. (Holding answer 8 July 2002).
To ask the Secretary of State for Health, if he intends to restrict the use of typical anti-psychotic drugs to a named patient basis. (Holding answer 8 July 2002).
To ask the Secretary of State for Health, what representations he has received concerning the implementation of the NICE guidance on atypical anti-psychotic drugs. (Holding answer 8 July 2002).
To ask the Secretary of State for Health, what representations he has received concerning the implementation of the NICE guidance on atypical anti-psychotic drugs. (Holding answer 8 July 2002).
To ask the Secretary of State for Health, whether he intends to use powers under section 97(6) of the National Health Service Act 1977 to ring-fence funds for the implementation of NICE guidance; and if he will make a statement as to his policy on the use of section 97(6)....
To ask the Secretary of State for Health, whether he intends to use powers under section 97(6) of the National Health Service Act 1977 to ring-fence funds for the implementation of NICE guidance; and if he will make a statement as to his policy on the use of section 97(6)....
To ask the Secretary of State for Health, when he expects to make a decision on the provision of recombinant to haemophiliacs. - Ref to 11 June 2002 at 386 c1212W. (Holding answer 4 July 2002).
To ask the Secretary of State for Health, when he expects to make a decision on the provision of recombinant to haemophiliacs. - Ref to 11 June 2002 at 386 c1212W. (Holding answer 4 July 2002).
To ask the Secretary of State for Health, pursuant to his Answer of 10th April, Official Report, column, 457W, on mental health, what conclusions have emerged from the work of the Homelessness Directorate as to the reasons for refusals of offers of help by rough sleepers in so far as...
To ask the Secretary of State for Health, pursuant to his Answer of 10th April, Official Report, column, 457W, on mental health, what conclusions have emerged from the work of the Homelessness Directorate as to the reasons for refusals of offers of help by rough sleepers in so far as...
To ask the Secretary of State for Health, what recent assessment he has made of the benefits of early treatment for those with mental health problems.
To ask the Secretary of State for Health, what recent assessment he has made of the benefits of early treatment for those with mental health problems.